Biomed Central Ltd

SHERPA: Unknown

People

  1. Postow
    Postow
  2. Assel
    Assel
  3. Blouin
    Blouin
  4. Diamond
    Diamond
  5. Klebanoff
    Klebanoff
  6. Ladanyi
    Ladanyi
  7. Rosa
    Rosa
  8. Sanchez Vega
    Sanchez Vega
  9. Smithy
    Smithy
  10. Tan
    Tan

Groups

  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (6)
  3. Melanoma Disease Management Team (4)
  4. Epidemiology and Biostatistics (3)
  5. GSK Faculty (3)
  6. Melanoma and Immunotherapeutics Service (3)
  7. Department of Pathology and Laboratory Medicine (2)
  8. Graduate Medical Education (2)
  9. Human Oncology and Pathogenesis Program (2)
  10. Population Sciences Research Program (2)
Search Within
  1. "Editorial"
Formats
  1. Editorial (10)
Groups
  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (6)
  3. Melanoma Disease Management Team (4)
  4. Epidemiology and Biostatistics (3)
  5. GSK Faculty (3)
  6. Melanoma and Immunotherapeutics Service (3)

More Groups

People
  1. Michael Postow (3)
  2. Amanda Blouin (1)
  3. Andrew Vickers (1)
  4. Christopher Klebanoff (1)
  5. Francisco Sanchez Vega (1)
  6. James Smithy (1)

More People

Years
  1. 2025 (2)
  2. 2024 (1)
  3. 2023 (1)
  4. 2022 (1)
  5. 2021 (2)
  6. 2020 (2)

More Years

Publications
  1. Journal of Translational Medicine (3)
  2. Journal for ImmunoTherapy of Cancer (2)
  3. BMC Medicine (1)
  4. Diagnostic and Prognostic Research (1)
  5. Genome Biology (1)
  6. Genome Medicine (1)

More Publications

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Advocating for collaboration among key partners to promote diversity in clinical studies amid policy challenges in the United States of America
    Editorial

    Byiringiro, S.; Garcia, J. K.; Farrell, N.; Ogungbe, B.; Barsha, R. A. A.; Miller, H. N.; Whitaker, E.; Wang, P.; Rosa, W. E.; Bierer, B. E.; more...
    Trials (2025)

    Fulltext@MSK | Save
  • Against reflexive recalibration: Towards a causal framework for addressing miscalibration
    Editorial

    Swaminathan, A.; Srivastava, U.; Tu, L.; Lopez, I.; Shah, N. H.; Vickers, A. J.
    Diagnostic and Prognostic Research (2025)

    Fulltext@MSK | Save
  • Suppressive effects of obesity on NK cells: Is it time to incorporate obesity as a clinical variable for NK cell-based cancer immunotherapy regimens?
    Editorial

    Canter, R. J.; Judge, S. J.; Collins, C. P.; Yoon, D. J.; Murphy, W. J.
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Perspectives in immunotherapy: Meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022)
    Editorial

    Ascierto, P. A.; Avallone, A.; Bifulco, C.; Bracarda, S.; Brody, J. D.; Emens, L. A.; Ferris, R. L.; Formenti, S. C.; Hamid, O.; Johnson, D. B.; more...
    Journal of Translational Medicine (2023)

    Fulltext@MSK | Save
  • Ensuring equity in the era of HLA-restricted cancer therapeutics
    Editorial

    Smithy, J. W.; Blouin, A.; Diamond, L. C.; Postow, M.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Perspectives in melanoma: Meeting report from the Melanoma Bridge (December 3rd–5th, 2020, Italy)
    Editorial

    Ascierto, P. A.; Blank, C.; Dummer, R.; Ernstoff, M. S.; Ferrone, S.; Fox, B. A.; Gajewski, T. F.; Garbe, C.; Hwu, P.; Kalinski, P.; more...
    Journal of Translational Medicine (2021)

    Fulltext@MSK | Save
  • Unraveling the cartography of the cancer ecosystem
    Editorial

    Rabbie, R.; Lau, D.; White, R. M.; Adams, D. J.
    Genome Biology (2021)

    Fulltext@MSK | Save
  • Perspectives in melanoma: Meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)
    Editorial

    Ascierto, P. A.; Puzanov, I.; Agarwala, S. S.; Blank, C.; Carvajal, R. D.; Demaria, S.; Dummer, R.; Ernstoff, M.; Ferrone, S.; Fox, B. A.; more...
    Journal of Translational Medicine (2020)

    Fulltext@MSK | Save
  • The use and drawbacks of risk-grouping in prediction models
    Editorial

    Tan, K. S.; Assel, M.
    BMC Medicine (2020)

    Fulltext@MSK | Save
  • Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
    Editorial

    Ladanyi, M.; Sanchez Vega, F.; Zauderer, M.
    Genome Medicine (2019)

    Fulltext@MSK | Save